Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000950170-23-051615

Options or other derivatives

  • Director acquired 2,170 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ros Matthew · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-10-02 Grant or award : show line 1 in the form Stock Option (Right to Buy) +2,170 2,170 D
Loading xslF345X05/ownership.xml…